University of Washington spinout A-Alpha Bio snags $20M for protein-discovery platform

09 Sep, 2021

University of Washington spinout A-Alpha Bio snags $20M for protein-discovery platform
Photo by Álvaro Serrano on Unsplash

– A-Alpha Bio, a drug development platform company, raised $20m funding.
– The funding was led by Seattle’s Madrona Venture Group and joined by other investors.
– The company plans to build lab space in downtown Seattle and beef up its machine learning team with the funding.
– The company uses information from its datasets to train its algorithms to predict favorable protein interactions.

Biotechnology Health Care North America Product Design
Crunchbase icon

Content report

The following text will be sent to our editors: